Determination of serum 7-ketocholesterol concentrations and their relationships with coronary multiple risks in diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 80, Issue 1, 2008, Pages 63-68

  Endo, Kei ^a   Oyama, Tomokazu ^a   Saiki, Atsuhito ^a   Ban, Noriko ^a   Ohira, Masahiro ^a   Koide, Nobukiyo ^a   Murano, Takeyoshi ^a   Watanabe, Hitoshi ^a   Nishii, Manabu ^b   Miura, Minoru ^b   Sekine, Kyoichi ^b   Miyashita, Yoh ^a   Shirai, Koji ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

^b Mitsubishi Kagaku Biochem Labs   (Japan)

Author keywords

Insulin resistance; LDL C; Metabolic syndrome; Serum 7 ketocholesterol; Type 2 diabetes mellitus

Indexed keywords

7 OXOCHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; QUANTITATIVE ASSAY;

BIOLOGICAL MARKERS; CHEMISTRY, CLINICAL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; KETOCHOLESTEROLS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 41049109537     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.10.023     Document Type: Article

References (30)

1. Fuster V., Stein B., Ambrose J.A., Badimon L., Badimon J.J., and Chesebro J.H. Atherosclerotic plaque rupture and thrombosis. Circulation 82 Suppl (1990) II-47-II-59
2. Brown A.J., and Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 142 (1998) 1-28
3. Smith L.L. Review of progress in sterol oxidations: 1987-1995. Lipids 31 (1996) 453-487
4. Sevanian A., Berliner J., and Peterson A.R. Uptake, metabolism and cytotoxicity of isomeric cholesterol-5,6-epoxides in rabbit aortic endothelial cells. J Lipids Res 32 (1991) 147-155
5. Sevanian A., Hodis H.N., Hwang J., and Peterson H. Involvement of cholesterol oxides in the atherogenic action of oxidized LDL. In: Bellomo G., Finardi G., Maggi E., and Rice-Evans C. (Eds). Free radicals, lipoprotein oxidation and atherosclerosis. 1st ed. (1995), Eichelieu Press, London, England 139-161
6. Palladini G., Finardi G., and Bellomo G. Disruption of actin microfilament organization by cholesterol oxides in 73/73 endothelial cells. Exp Cell Res 223 (1996) 72-82
7. Boissonneault G.A., Hennig B., Wang Y., Ouyang C.M., Krahulik L., Cunnup L., et al. Effect of oxysterol-enriched low-density lipoproteins. Ann Nutr Metab 35 (1991) 226-232
8. Boissonneault G.A., Hennig B., and Ouyang C.M. Oxysterols, cholesterol biosynthesis, and vascular endothelial cell monolayer barrier function. Proc Soc Exp Biol Med 196 (1991) 338-343
9. Deckert V., Brunet A., Lantoine F., Lizard G., Brussel E.M., Monier S., et al. Inhibition by cholesterol oxides of NO release from human vascular endothelial cells. Arterioscler Thromb Vasc Bio 18 (1998) 1054-1060
10. Deckert V., Persegol L., Viens L., Lizard G., Athias A., Lallemant C., et al. Inhibition of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 95 (1997) 723-731
11. Miyashita Y., Shirai K., Ito Y., Watanabe J., Urano Y., Murano T., et al. Cytotoxicity of some oxysterols on human vascular smooth muscle cells was mediated by apoptosis. J Atheroscler Thromb 4 (1997) 73-78
12. Urano Y., Shirai K., Watanabe H., Miyasita Y., and Hasiguti S. Vascular smooth muscle cell outgrowth, proliferation, and apoptosis in young and old rats. Atherosclerosis 146 (1999) 101-105
13. Oyama T., Miyashita Y., Kinoshita K., Watanabe H., Shirai K., and Yagima T. Effect of deposited lipids in atheromatous lesions on the migration of vascular smooth muscle cells. J Atheroscler Thromb 9 (2001) 109-113
14. Baynes J.W. Role of oxidative stress in development of complication in diabetes. Diabetes 40 (1991) 405-412
15. Sharma A., Kharb S., Chugh S.N., Kakkar R., and Singh G.P. Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplement in diabetic patients. Metabolism 49 (2000) 166-162
16. Nishikawa T., Sasahara T., Kiritoshi S., Sonoda K., Senokuchi T., Matsuo T., et al. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 26 (2003) 1507-1512
17. Nakanishi S., Suzuki G., Kusunoki Y., Kimura K., Egusa G., and Kohno N. Increasing of oxidative stress from mitochondria in type 2 diabetic patients. Diabetes Metab Res Rev 20 (2004) 399-404
18. Kannnel W.B., and McGee D.L. Diabetes and cardiovascular disease, the Framingham study. JAMA 241 (1979) 2035-2038
19. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16 (1993) 434-444
20. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Tech. Rep. Ser. no.727. Geneva: World Health Organization, 1985.
21. National Institute of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Publication 01-3670. Bethesda, MD: National Institute of Health; 2001.
22. Guan J.Z., Murakami H., Yamato K., Tanabe J., Matui J., Tamasawa N., et al. Effect of fluvastatin in type 2 diabetic patients with hyperlipidemia: reduction in cholesterol oxidation products and VCAM-1. J Atheroscler Thromb 11 (2004) 56-61
23. Diczfalusy U. Analysis of cholesterol oxidation products in biological samples. J AOAC Int 87 (2004) 467-473
24. Reaven G.M. The role of insulin resistance and hyperinsulinemia in coronary heart disease. Metabolism 41 (1992) 16-19
25. Baynes J.W., and Thorpe S.R. The role of oxidative stress in diabetic complications. Curr Opin Endocrinol 3 (1997) 277-284
26. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. JCI 114 (2004) 1752-1761
27. Giugliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19 (1996) 257-267
28. Quinn M.T., Parthasarathy S., Fong L.G., and Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84 (1987) 2995-2998
29. Porkkala-Sarataho E., Salonen J.T., Nyyssonen K., Kaikkonen J., Salonen R., Ristonmaa U., et al. Long-term effects of vitamin E, vitamin C, and combined supplementation on urinary 7-hydro-8-oxo-2′-deoxyguanosine, serum cholesterol oxidation products, and oxidation resistance of lipids in nondepleted men. Arterioscler Thromb Vasc Biol 20 (2000) 2087-2093
30. Iuliano L., Micheletta F., Maranghi M., Frati G., Diczfalusy U., and Violi F. Bioavailability of vitamin E as function of food intake in healthy subjects: effects on plasma peroxide-scavenging activity and cholesterol-oxidation products. Arterioscler Thromb Vasc Biol 21 (2001) E34-E37